4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as Btk inhibitors
US9290504B2 · kind B2 · utility
23Cited by
4References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2012 |
| Grant date | Mar 22, 2016 |
| Priority date | — |
| Expiry date | Jul 11, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to 6-5 membered fused pyridine ring compounds according to formula (I) or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 membered fused pyridine ring compounds according to formula I in the treatment of Brutons Tyrosine Kinase (Btk) mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.